Where there’s a will, there’s a way. Patients are our will.
Status – Pivotal Phase 2/3 study began enrollment 4Q19; Filing initiation began December 2020
Study Sponsor – Cardiff University (for AML18, AML19)
For Vyxeos® (daunorubicin and cytarabine) full Prescribing Information, including Boxed WARNING, please visit www.jazzpharma.com/medicines/our-medicines
Study Sponsor – MD Anderson Cancer Center
For Defitelio® full Prescribing Information, please visit www.jazzpharma.com/medicines/our-medicines.